Purchase Order 36C24518P3451
- Not listed
- The Department of Veterans Affairs (VA) awarded a $112,052.25 firm fixed-price purchase order to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The contract is for the delivery of nuclear medicine products such as Lutetium Lu 177 Dotatate, Lutetium Lu 177 Vipivotide Tetraxetan, gallium Ga 68 dotatate, and Ga-68 Dotatate injections to VA medical centers and integrated service networks across the country. This contract is not set...
- This is a $187,035.70 firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceutical products. The order is placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and provides Lutetium Lu 177 Dotatate, a radiopharmaceutical used in targeted radioligand therapy and nuclear medicine. Advanced Accelerator...
- The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed price delivery order to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals, to provide 3 doses of Lutetium Dotatate. The $112,221.42 contract was awarded on June 3, 2021, with a completion date of December 31, 2021. This order was placed through the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. Advanced Accelerator Applications USA...
- The Department of Veterans Affairs Veterans Health Administration awarded a $296,967.82 firm fixed price delivery order to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The order is for 16 doses of the radioligand therapy drug LUTATHERA (Lutetium Lu 177) to treat 4 patients. The contract does not utilize any set-asides and has a completion date of September 30, 2019. Advanced Accelerator Applications USA Inc. holds several federal...
- This is a $2,476,989.38 delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceutical products. The contract is for the delivery of radiopharmaceuticals, including PLUVICTO, LUTATHERA, and other nuclear medicine products, to support diagnostic imaging, cancer treatment, and other medical applications at VA medical facilities. The contract is...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a radiopharmaceutical company that specializes in targeted radioligand therapy and nuclear medicine. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with a firm fixed price of $1,075,962.94 and a completion date of April 30, 2021. It was not set aside for any specific business type....
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 10 to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The $148,377.88 firm fixed-price purchase order is for the delivery of the drug LUTATHERA, which is used in targeted radioligand therapy and nuclear medicine. Advanced Accelerator Applications USA Inc. is a provider of radiopharmaceutical goods and...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The contract has a potential value of $598,514.24 and a completion date of February 29, 2024. It was awarded on March 1, 2021 under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract provides the VA...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The $110,600 firm-fixed-price contract is for the delivery of Lutetium Lu 177 Dotatate, a radiopharmaceutical used in nuclear medicine, to VA medical centers and VA Integrated Service Networks across the country. The contract was awarded through the VA's...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $198,235.70 firm fixed price delivery order for Lutetium Lu 177 Dotatate to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. Advanced Accelerator Applications USA Inc. provides radiopharmaceutical products and services to various federal agencies,...
This is a $462,715.00 firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals. The contract is for the delivery of various radiopharmaceutical products including Lutetium Lu 177 Dotatate, Lutetium Lu 177 Vipivotide Tetraxetan, gallium Ga 68 dotatate, and Ga-68 Dotatate injections to VA medical centers and integrated service networks. This award was not set aside for any small business category. Advanced Accelerator Applications USA Inc. holds several Federal Supply Schedule and Blanket Purchase Agreement vehicles with the VA to provide radiopharmaceuticals such as PLUVICTO and LUTATHERA, indicating this is part of the company's larger federal contracting portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00010 | Supplemental Agreement for work within scope | ($88k) | 2/7/23 | |
| P00008 | Supplemental Agreement for work within scope | ($67k) | 9/21/22 | |
| P00009 | Supplemental Agreement for work within scope | ($3k) | 9/21/22 | |
| P00007 | Supplemental Agreement for work within scope | ($12k) | 9/21/22 | |
| P00006 | Exercise an Option | $112.0k | 6/29/21 |